During the past decade, Vince Lombardi Cancer Clinic - Oshkosh conducted 140 clinical trials. In the 10-year time frame, 140 clinical trials started and 82 clinical trials were completed, i.e. on average, 58.6% percent of trials that started reached the finish line to date. In the past 5 years, 51 clinical trials started and 68 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vince Lombardi Cancer Clinic - Oshkosh" #1 sponsor was "National Cancer Institute (NCI)" with 84 trials, followed by "SWOG Cancer Research Network" with 30 trials sponsored, "Alliance for Clinical Trials in Oncology" with 25 trials sponsored, "NRG Oncology" with 19 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 19 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vince Lombardi Cancer Clinic - Oshkosh" #1 collaborator was "National Cancer Institute (NCI)" with 114 trials as a collaborator, "NRG Oncology" with 27 trials as a collaborator, "Canadian Cancer Trials Group" with 11 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator and "Genentech, Inc." with 5 trials as a collaborator. Other collaborators include 43 different institutions and companies that were collaborators in the rest 38 trials.

According to Clinical.Site data, the most researched conditions in "Vince Lombardi Cancer Clinic - Oshkosh" are "Breast Cancer" (15 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Invasive Breast Carcinoma" (9 trials), "Recurrent Ovarian Carcinoma" (9 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials). Many other conditions were trialed in "Vince Lombardi Cancer Clinic - Oshkosh" in a lesser frequency.

Most popular intervention types in "Vince Lombardi Cancer Clinic - Oshkosh" are "Drug" (159 trials), "Other" (128 trials), "Biological" (76 trials), "Procedure" (52 trials) and "Radiation" (45 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (63 trials), "Laboratory Biomarker Analysis" (59 trials), "Questionnaire Administration" (37 trials), "Paclitaxel" (28 trials) and "Carboplatin" (26 trials). Other intervention names were less common.

The vast majority of trials in "Vince Lombardi Cancer Clinic - Oshkosh" are 142 trials for "All" genders, 48 trials for "Female" genders and 12 trials for "Male" genders.

Currently, there are NaN active trials in "Vince Lombardi Cancer Clinic - Oshkosh". undefined are not yet recruiting, 47 are recruiting, 109 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 33 completed trials in Vince Lombardi Cancer Clinic - Oshkosh, 6 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Vince Lombardi Cancer Clinic - Oshkosh, 3 "Phase 1" clinical trials were conducted, 83 "Phase 2" clinical trials and 124 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".